FIELD: medicine, otorhinolaryngology. SUBSTANCE: method involves administration of human ceruloplasmin by intravenous drop route at dose 1.5 mg/kg/day for 5-7 days to patients with decreased blood protein ceruloplasmin level and increased content of substances of molecular mass 300-5000 Da. Method ensures to increase hearing function by 10-35 dB at both acute and chronic disorder forms for short treatment course. EFFECT: enhanced effectiveness of treatment. 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF REVEALING NEUROSENSOR HEARING DISORDER AND ITS GROUP OF RISK | 1995 |
|
RU2084898C1 |
METHOD FOR TREATING MENIERE DISEASE | 1996 |
|
RU2104044C1 |
METHOD FOR DETERMINING INDICATIONS TO PLASMAPHERESIS ADMINISTRATION IN CASES OF MENIERE DISEASE | 1996 |
|
RU2099712C1 |
METHOD OF TREATING NEUROSENSOR HEARING DISORDER | 1995 |
|
RU2085232C1 |
METHOD TO TREAT TONSILLITIS | 1997 |
|
RU2110301C1 |
METHOD OF TOPICAL DIAGNOSTICS OF ACOUSTIC ANALYZER DAMAGE | 1995 |
|
RU2095023C1 |
METHOD FOR EXAMINING AUDITORY FUNCTION | 1999 |
|
RU2148949C1 |
METHOD FOR TREATING THE CASES OF EXTERNAL OTITIS | 2000 |
|
RU2163794C1 |
METHOD FOR IMPROVING AUDITORY FUNCTION IN THE CASES OF TYMPANOSCLEROSIS | 2002 |
|
RU2223084C1 |
METHOD FOR THE TREATMENT OF ACUTE ACOUSTIC INJURY | 2022 |
|
RU2783255C1 |
Authors
Dates
1998-04-20—Published
1996-06-20—Filed